-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly Accrued Liabilities, Current history and change rate from Q4 2020 to Q2 2023.
- Ambrx Biopharma Cayman, Inc. Accrued Liabilities, Current for the quarter ending 30 Jun 2023 was $9,556,000.000, a 38.7% decline year-over-year.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Change (%)